These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Glycine regulates the production of pro-inflammatory cytokines in lean and monosodium glutamate-obese mice. Alarcon-Aguilar FJ, Almanza-Perez J, Blancas G, Angeles S, Garcia-Macedo R, Roman R, Cruz M. Eur J Pharmacol; 2008 Dec 03; 599(1-3):152-8. PubMed ID: 18930730 [Abstract] [Full Text] [Related]
4. Effects of bezafibrate in nonalcoholic steatohepatitis model mice with monosodium glutamate-induced metabolic syndrome. Sasaki Y, Shimada T, Iizuka S, Suzuki W, Makihara H, Teraoka R, Tsuneyama K, Hokao R, Aburada M. Eur J Pharmacol; 2011 Jul 15; 662(1-3):1-8. PubMed ID: 21549692 [Abstract] [Full Text] [Related]
5. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B. Eur Cytokine Netw; 2006 Mar 15; 17(1):4-12. PubMed ID: 16613757 [Abstract] [Full Text] [Related]
6. Anti-inflammatory effect of atorvastatin ameliorates insulin resistance in monosodium glutamate-treated obese mice. Furuya DT, Poletto AC, Favaro RR, Martins JO, Zorn TM, Machado UF. Metabolism; 2010 Mar 15; 59(3):395-9. PubMed ID: 19800637 [Abstract] [Full Text] [Related]
7. The effects of obesity-associated insulin resistance on mRNA expression of peroxisome proliferator-activated receptor-gamma target genes, in dogs. Gayet C, Leray V, Saito M, Siliart B, Nguyen P. Br J Nutr; 2007 Sep 15; 98(3):497-503. PubMed ID: 17475082 [Abstract] [Full Text] [Related]
8. [Effects of conjugated linoleic acid on obese MSG mice with insulin resistance]. Sun SJ, Shen ZF, Chen YT, Tang L, Ding SY, Xie MZ. Yao Xue Xue Bao; 2003 Dec 15; 38(12):904-7. PubMed ID: 15040081 [Abstract] [Full Text] [Related]
9. Glucose tolerance and insulin action in monosodium glutamate (MSG) obese exercise-trained rats. de Mello MA, de Souza CT, Braga LR, dos Santos JW, Ribeiro IA, Gobatto CA. Physiol Chem Phys Med NMR; 2001 Dec 15; 33(1):63-71. PubMed ID: 11758736 [Abstract] [Full Text] [Related]
10. Subcutaneous and visceral adipose tissue gene expression of serum adipokines that predict type 2 diabetes. Samaras K, Botelho NK, Chisholm DJ, Lord RV. Obesity (Silver Spring); 2010 May 15; 18(5):884-9. PubMed ID: 20019678 [Abstract] [Full Text] [Related]
11. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice. Cong WN, Tao RY, Tian JY, Liu GT, Ye F. Life Sci; 2008 May 07; 82(19-20):983-90. PubMed ID: 18417155 [Abstract] [Full Text] [Related]
12. Prolonged treatment of genetically obese mice with conjugated linoleic acid improves glucose tolerance and lowers plasma insulin concentration: possible involvement of PPAR activation. Wargent E, Sennitt MV, Stocker C, Mayes AE, Brown L, O'Dowd J, Wang S, Einerhand AW, Mohede I, Arch JR, Cawthorne MA. Lipids Health Dis; 2005 Jan 10; 4():3. PubMed ID: 15642120 [Abstract] [Full Text] [Related]
13. Glycine regulates inflammatory markers modifying the energetic balance through PPAR and UCP-2. Almanza-Perez JC, Alarcon-Aguilar FJ, Blancas-Flores G, Campos-Sepulveda AE, Roman-Ramos R, Garcia-Macedo R, Cruz M. Biomed Pharmacother; 2010 Oct 10; 64(8):534-40. PubMed ID: 19864106 [Abstract] [Full Text] [Related]
14. Adiponectin and resistin response in the onset of obesity in male and female rats. Ribot J, Rodríguez AM, Rodríguez E, Palou A. Obesity (Silver Spring); 2008 Apr 10; 16(4):723-30. PubMed ID: 18239591 [Abstract] [Full Text] [Related]
15. Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance. Baranova A, Gowder SJ, Schlauch K, Elariny H, Collantes R, Afendy A, Ong JP, Goodman Z, Chandhoke V, Younossi ZM. Obes Surg; 2006 Sep 10; 16(9):1118-25. PubMed ID: 16989692 [Abstract] [Full Text] [Related]
16. Effect of trans-fat, fructose and monosodium glutamate feeding on feline weight gain, adiposity, insulin sensitivity, adipokine and lipid profile. Collison KS, Zaidi MZ, Saleh SM, Inglis A, Mondreal R, Makhoul NJ, Bakheet R, Burrows J, Milgram NW, Al-Mohanna FA. Br J Nutr; 2011 Jul 10; 106(2):218-26. PubMed ID: 21429276 [Abstract] [Full Text] [Related]
18. Muraglitazar, a novel dual (alpha/gamma) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves beta-cell function in db/db mice. Harrity T, Farrelly D, Tieman A, Chu C, Kunselman L, Gu L, Ponticiello R, Cap M, Qu F, Shao C, Wang W, Zhang H, Fenderson W, Chen S, Devasthale P, Jeon Y, Seethala R, Yang WP, Ren J, Zhou M, Ryono D, Biller S, Mookhtiar KA, Wetterau J, Gregg R, Cheng PT, Hariharan N. Diabetes; 2006 Jan 10; 55(1):240-8. PubMed ID: 16380499 [Abstract] [Full Text] [Related]
19. Dose dependent development of diabetes mellitus and non-alcoholic steatohepatitis in monosodium glutamate-induced obese mice. Sasaki Y, Suzuki W, Shimada T, Iizuka S, Nakamura S, Nagata M, Fujimoto M, Tsuneyama K, Hokao R, Miyamoto K, Aburada M. Life Sci; 2009 Sep 23; 85(13-14):490-8. PubMed ID: 19683013 [Abstract] [Full Text] [Related]
20. Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats. Choi KC, Ryu OH, Lee KW, Kim HY, Seo JA, Kim SG, Kim NH, Choi DS, Baik SH, Choi KM. Biochem Biophys Res Commun; 2005 Oct 28; 336(3):747-53. PubMed ID: 16157299 [Abstract] [Full Text] [Related] Page: [Next] [New Search]